During the past decade, MediSync Clinical Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MediSync Clinical Research" are "Colorectal Cancer" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "MediSync Clinical Research" in a lesser frequency.

Most popular intervention types in "MediSync Clinical Research" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood Sample Collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "MediSync Clinical Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "MediSync Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MediSync Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MediSync Clinical Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".